BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1359 related articles for article (PubMed ID: 19485249)

  • 21. [Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].
    Bozkowa K; Cabalska B; Radomyska B; Ołtarzewski M; Lenartowska I
    Med Wieku Rozwoj; 1999; 3(4):529-59. PubMed ID: 10910678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydrobiopterin and maternal PKU.
    Koch R; Moseley K; Guttler F
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S139-41. PubMed ID: 16338627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What disorders suspect following an increase of phenylalanine on newborn screening?].
    Michel MA; Raucourt E; Bednarek N; Garnotel R
    Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of phenylketonuria in the very early newborn blood specimen.
    Doherty LB; Rohr FJ; Levy HL
    Pediatrics; 1991 Feb; 87(2):240-4. PubMed ID: 1987536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis, treatment and long-term following up of 223 patients with hyperphenylalaninemia detected by neonatal screening programs].
    Ye J; Qiu WJ; Han LS; Zhang YJ; Zhou JD; Zhang YF; Wu YL; Gu XF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 May; 41(3):189-92. PubMed ID: 17708870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of phenylketonuria by the newborn screening program in Thailand.
    Pangkanon S; Charoensiriwatana W; Janejai N; Boonwanich W; Chaisomchit S
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):525-9. PubMed ID: 19842439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperphenylanalinemia and phenylketonuria. The importance of early diagnosis and follow up at a health center].
    Campistol Plana J; Alvarez Domińguez L; Riverola de Veciana AT; Castillo Rivera P; Giner Soria P
    An Esp Pediatr; 1991 Jan; 34(1):51-6. PubMed ID: 2018258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience based on 800,000 newborn screening tests of the Budapest Phenylketonuria Centre.
    Szabó L; Somogyi C; Máté M
    Acta Paediatr Hung; 1985; 26(2):113-25. PubMed ID: 4041279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild hyperphenylalaninemia and heterozygosity of the phenylalanine hydroxylase gene.
    Koch R; Güttler F; Guldberg P; Rouse B
    Mol Genet Metab; 1998 Feb; 63(2):148-50. PubMed ID: 9562969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.
    Fiege B; Bonafé L; Ballhausen D; Baumgartner M; Thöny B; Meili D; Fiori L; Giovannini M; Blau N
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S91-5. PubMed ID: 16290003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of phenylketonuria in Thailand.
    Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P
    J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal screening for congenital hypothyroidism and phenylketonuria at Siriraj Hospital, Mahidol University, Bangkok, Thailand--a pilot study.
    Wasant P; Liammongkolkul S; Srisawat C
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():33-7. PubMed ID: 11400774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The National Institute of Child Health and Human Development and phenylketonuria.
    Alexander D
    Pediatrics; 2003 Dec; 112(6 Pt 2):1514-5. PubMed ID: 14654655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria.
    Boneh A; Francis DE; Humphrey M; Upton HJ; Peters HL
    J Paediatr Child Health; 2006 Sep; 42(9):496-8. PubMed ID: 16925533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [12 years Austrian newborn screening for inborn errors of metabolism. Results with special reference to phenylketonuria, hyperphenylalaninemia and histidinemia (author's transl)].
    Thalhammer O; Scheibenreiter S; Knoll E; Wehle E; Schön R
    Klin Padiatr; 1980 Nov; 192(6):589-98. PubMed ID: 7194400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn screening for PKU and congenital hypothyroidism in Latvia.
    Lugovska R; Vevere P; Andrusaite R; Kornejeva A
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():52-3. PubMed ID: 11400783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some factors affecting McCaman-Robins test results in screening newborns for PKU.
    Kleinman DS; Twiss S; Day RW
    Pediatrics; 1966 Oct; 38(4):619-28. PubMed ID: 5922178
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia.
    Shakespeare L; Downing M; Allen J; Casbolt AM; Ellin S; Maloney M; Race G; Bonham J
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):567-9. PubMed ID: 20947531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in newborn screening for phenylketonuria.
    Koch RK
    Am Fam Physician; 1999 Oct; 60(5):1462-6. PubMed ID: 10524490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.